• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2 3 4 5 6 7 8 Next >
    More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
    Tags Business News Biotech and Pharmaceuticals Health care industry
    From CNBC.com News
    Most people on weight loss drugs are spending less on restaurants and takeout, survey says
    Tags Health & Science Diageo PLC Wingstop Inc
    From CNBC.com News
    Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
    Tags Novo Nordisk A/S Business US: News
    From CNBC.com News
    Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
    Tags Eli Lilly and Co Science Health & Science
    From CNBC.com News
    EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
    Tags Health care industry Biotech and Pharmaceuticals Business News
    From CNBC.com News
    Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
    Tags Companies Health & Science Science
    From CNBC.com News
    Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
    Tags Business News Novo Nordisk A/S Europe News
    From CNBC.com News
    Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
    Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
    From CNBC.com News
    Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
    Tags Biotech and Pharmaceuticals Business News Health care industry
    From CNBC.com News
    Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
    Tags Pharmaceuticals US: News Business
    From CNBC.com News
    Viking Therapeutics stock jumps 15% on promising weight loss pill data
    Tags Health & Science Companies Science
    From CNBC.com News
    Amgen wants in on the booming weight loss drug market — and it's taking a different approach
    Tags Eli Lilly and Co Health & Science Companies
    From CNBC.com News
    Two fresh ways to play the weight loss and megacap tech hype
    Tags stocks Breaking News: Investing Markets
    From CNBC.com News
    Here's how much people are willing to spend on weight loss drugs, according to a new survey
    Tags Companies Health & Science Eli Lilly and Co
    From CNBC.com News
    Cramer's Lighting Round: Arm is a buy
    Tags Unity Software Inc General Electric Co Market Outlook
    From CNBC.com News
    Medicare can now cover certain weight loss drugs in a big step for patients
    Tags Novo Nordisk A/S Biotechnology US: News
    From CNBC.com News
    Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
    Tags Akero Therapeutics Inc Alphabet Inc GE HealthCare Technologies Inc
    From CNBC.com News
    Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
    Tags Companies Insurance industry Health & Science
    From CNBC.com News
    FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
    Tags Pharmaceuticals Business US: News
    From CNBC.com News
    Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
    Tags Eli Lilly and Co Weight loss diets Pharmaceuticals
    From CNBC.com News
    Experts hesitate on weight loss ETFs amid the obesity drug boom
    Tags Exchange/traded funds U/S/ Markets Health
    From CNBC.com News
    Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
    Tags CVS Health Corp Eli Lilly and Co Amazon/com Inc
    From CNBC.com News
    Jim Cramer reviews Citi's European 'Super Seven'
    Tags Business News Stock Picks U/S/ Markets
    From CNBC.com News
    Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
    Tags Novo Nordisk A/S Social issues Business News
    From CNBC.com News
    Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
    Tags Biotechnology Health care industry US: News
    From CNBC.com News
    Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
    Tags Pharmaceuticals Markets Tesla Inc
    From CNBC.com News
    Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
    Tags Health care industry Investing Europe Markets
    From CNBC.com News
    Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
    Tags Biotech and Pharmaceuticals Business News Health care industry
    From CNBC.com News
    Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
    Tags Markets Stock markets Investment strategy
    From CNBC.com News
    Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
    Tags Breaking news Pharmaceuticals US: News
    From CNBC.com News
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.